EBD Group

🤝 Conducting the brain: What’s next in neuroscience? - With innovation and bold collaborations leading the way, explore the new era of Neuroscience! 📍 BIO-Europe 🌍 Vienna, Austria 📆 November 4, 2025 🕖 16:30 – 17:15 Find out what else is on the agenda >> http://spr.ly/6049AcbhU #BIOEurope #EBDGroup #Vienna #Neuroscience

📍 3 day free webinar series: BioXconomy Digital Week   📝 Find out more & secure your spot here >> https://lnkd.in/ec3jb6mz   From Lab to Leadership: Building a High-Impact Biotech Team for Commercial Success   📅 02 October 2025 🕘 11:00am ET Moving from scientific discovery to commercial success in biotech requires more than breakthrough products—it calls for a visionary and cohesive leadership team that can drive both scientific and commercial goals. This panel will bring together experienced biotech leaders to discuss strategies for building a biotech leadership team that can guide the company from lab to launch. Attendees will gain insights on selecting and developing leaders who can navigate the complexities of the biotech market and align teams around shared success. Key topics will include: 👉 Identifying the leadership qualities essential for guiding a biotech team from research to revenue 👉 Strategies for leaders to ensure cohesive communication of scientific value and clinical benefits to key stakeholders 👉 Fostering an environment where scientific and commercial leaders collaborate effectively to achieve market success  #Biopharma #partnering #Investment #Webinar

📍 3 day free webinar series: BioXconomy Digital Week   📝 Find out more & secure your spot here >> https://lnkd.in/ezYKq5bF   The Future of Neuromodulation is Here: The Partnership Between Neuroscience and Neurotechnology   📅 02 October 2025 🕘 10:00am ET Explore the groundbreaking intersection of neuroscience and neurotechnology in this forward-looking session. This expert presentation will examine recent scientific breakthroughs, discuss the transformative potential of neuromodulation therapies, and introduce Nu-V3's revolutionary approach to non-invasive treatment. Join us to understand how these innovations are reshaping patient care and opening new frontiers in neurological health management, and where we can go from here. 👉 Recent advancements in brain science, harnessing new insights into the biological mechanisms underlying neurological conditions. 👉 Understanding how neuromodulation techniques have evolved for treating neurological disorders 👉 How Nu-V3's miniaturized, wearable technology delivers non-invasive, non-pharmaceutical neuromodulation with no negative side effects. #Biopharma #partnering #Investment #Webinar

🌟 Thank You to Our BIO-Europe 2025 Platinum Sponsors We extend our sincere gratitude to all our Platinum Sponsors for their valuable support of BIO-Europe 2025 in Vienna, Austria. Your partnership helps make this premier life sciences partnering event possible. Your commitment to fostering innovation and collaboration in the global biopharma community is truly appreciated. We look forward to welcoming you to Vienna on November 3-5, 2025, for three days of productive networking, partnering, and knowledge exchange. Thank you for being an integral part of BIO-Europe's success! View the full list of BIO-Europe 2025 sponsors >> http://spr.ly/6049A5xMF #BIOEurope #Sponsors #Vienna

📍 3 day free webinar series: BioXconomy Digital Week   📝 Find out more & secure your spot here >> https://lnkd.in/ds3xdQUh   Closing the Books Strong: Q4 Biopharma Deal Landscape & 2025 Outlook   📅 01 October 2025 🕘 10:00am ET As the biopharma industry navigates the final quarter of a transformative year, strategic dealmaking and investment patterns offer critical signals for what lies ahead. This exclusive thought leadership session provides senior executives with actionable intelligence at a pivotal moment in the industry calendar. Join Tim Opler, Managing Director at Stifel, as he delivers incisive market analysis through a dynamic fireside discussion. Drawing on his extensive experience in life sciences investment banking, Opler will decode Q4 activity patterns and translate them into strategic foresight for the coming year. Session Highlights: 👉 Late-Year Deal Momentum: Uncover emerging patterns in Q4 partnering and M&A transactions that signal strategic priorities for industry leaders 👉 Capital Markets Pulse: Gain perspective on investor sentiment, valuation trends, and how financing conditions are reshaping deal structures 👉 Big Pharma's Strategic Pivot: Examine how portfolio gaps and pipeline evolution are driving new approaches to external innovation 👉 2025 Dealmaking Calendar: Identify key inflection points and opportunities to watch as you plan your engagement strategy for BIO-Europe and beyond #Biopharma #partnering #Investment #Webinar

⚖️ Is the blend of strategic services the secret ingredient to biotech success? - Having evolved from behind-the-scenes supporters to strategic partners, explore how CDMOs, CROs, etc. are shaping resilient, agile development strategies and the future of biotech-pharma collaborations. 📍 BIO-Europe 🌍 Vienna, Austria 📆 November 4, 2025 🕖 11:30 – 12:15 Find out what else is on the agenda >> http://spr.ly/6048AjfeA #BIOEurope #EBDGroup #Vienna #StrategicServices

Unlock the Future of Biopharma & Healthtech Investment Trends The biopharma and healthtech sectors are transforming rapidly, driving innovation and redefining investment strategies. As these industries continue to evolve, understanding the latest trends is crucial for staying ahead in this competitive landscape. Our new report, "Evolving Investment Patterns in Biopharma & Healthtech", offers a comprehensive analysis of the venture capital market, explores emerging VC deal trends, and delves into the latest partnership and M&A dynamics shaping the future of these industries. 📊 What’s inside? Biopharma & healthtech venture activities • Venture capital market overview • Key VC deal trends Biopharma partnership & M&A • Partnership & M&A market overview • Key trends in partnership & M&A Real-world case study: maximizing biopharma deal potential • Expert insights from Andy Smith, AlphaSense 📥 Download the report here: https://lnkd.in/e_8XKak4 🔄 Share this post with your network to spark conversations about the future of biopharma and healthtech investments. Let’s shape the future together!

🤝 partneringONE is officially open for BIO-Europe and the industry’s top decision-makers are ready to partner with you! With record-breaking attendance expected this year, BIO-Europe 2025 is set to be the largest and most impactful event in its history. Don’t miss your chance to be part of this unparalleled networking opportunity. Be a part of biotech growth! 📈 Since its inception in 1995, BIO-Europe has experienced consistent expansion in attendance, partnerships formed, and global reach. This remarkable trajectory reflects not just our growth, but the evolution of the entire biotechnology industry. Register now to get in on the partnering action and save up to €600 >> http://spr.ly/6044AkruC #BIOEurope #Vienna #Partnering #Connections #EBDGroup

📰 Have you got your Guardian copy yet? 📰 Thank you to Mediaplanet for orchestrating this vital campaign raising awareness about Rare Diseases. We extend our heartfelt gratitude to Action Medical Research, our enduring partners, for their crucial work supporting families like Digby's. ❣️ Read the full article here: https://lnkd.in/emFw5ztF